695 related articles for article (PubMed ID: 12177198)
1. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.
Sherer TB; Betarbet R; Stout AK; Lund S; Baptista M; Panov AV; Cookson MR; Greenamyre JT
J Neurosci; 2002 Aug; 22(16):7006-15. PubMed ID: 12177198
[TBL] [Abstract][Full Text] [Related]
2. Rotenone induces apoptosis via activation of bad in human dopaminergic SH-SY5Y cells.
Watabe M; Nakaki T
J Pharmacol Exp Ther; 2004 Dec; 311(3):948-53. PubMed ID: 15280438
[TBL] [Abstract][Full Text] [Related]
3. Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system.
Betarbet R; Canet-Aviles RM; Sherer TB; Mastroberardino PG; McLendon C; Kim JH; Lund S; Na HM; Taylor G; Bence NF; Kopito R; Seo BB; Yagi T; Yagi A; Klinefelter G; Cookson MR; Greenamyre JT
Neurobiol Dis; 2006 May; 22(2):404-20. PubMed ID: 16439141
[TBL] [Abstract][Full Text] [Related]
4. Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons.
Sharma SK; Ebadi M
Antioxid Redox Signal; 2003 Jun; 5(3):251-64. PubMed ID: 12880480
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of toxicity in rotenone models of Parkinson's disease.
Sherer TB; Betarbet R; Testa CM; Seo BB; Richardson JR; Kim JH; Miller GW; Yagi T; Matsuno-Yagi A; Greenamyre JT
J Neurosci; 2003 Nov; 23(34):10756-64. PubMed ID: 14645467
[TBL] [Abstract][Full Text] [Related]
6. Synergistic anti-Parkinsonism activity of high doses of B vitamins in a chronic cellular model.
Jia H; Liu Z; Li X; Feng Z; Hao J; Li X; Shen W; Zhang H; Liu J
Neurobiol Aging; 2010 Apr; 31(4):636-46. PubMed ID: 18639366
[TBL] [Abstract][Full Text] [Related]
7. Proteasome mediates dopaminergic neuronal degeneration, and its inhibition causes alpha-synuclein inclusions.
Sawada H; Kohno R; Kihara T; Izumi Y; Sakka N; Ibi M; Nakanishi M; Nakamizo T; Yamakawa K; Shibasaki H; Yamamoto N; Akaike A; Inden M; Kitamura Y; Taniguchi T; Shimohama S
J Biol Chem; 2004 Mar; 279(11):10710-9. PubMed ID: 14672949
[TBL] [Abstract][Full Text] [Related]
8. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures.
Testa CM; Sherer TB; Greenamyre JT
Brain Res Mol Brain Res; 2005 Mar; 134(1):109-18. PubMed ID: 15790535
[TBL] [Abstract][Full Text] [Related]
9. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein expression in HEK293 cells enhances the mitochondrial sensitivity to rotenone.
Orth M; Tabrizi SJ; Schapira AH; Cooper JM
Neurosci Lett; 2003 Nov; 351(1):29-32. PubMed ID: 14550906
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation.
Sherer TB; Kim JH; Betarbet R; Greenamyre JT
Exp Neurol; 2003 Jan; 179(1):9-16. PubMed ID: 12504863
[TBL] [Abstract][Full Text] [Related]
12. Progressive loss of dopaminergic neurons induced by unilateral rotenone infusion into the medial forebrain bundle.
Norazit A; Meedeniya AC; Nguyen MN; Mackay-Sim A
Brain Res; 2010 Nov; 1360():119-29. PubMed ID: 20807515
[TBL] [Abstract][Full Text] [Related]
13. Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease.
Sala G; Marinig D; Riva C; Arosio A; Stefanoni G; Brighina L; Formenti M; Alberghina L; Colangelo AM; Ferrarese C
Neurotoxicology; 2016 May; 54():161-169. PubMed ID: 27133439
[TBL] [Abstract][Full Text] [Related]
14. Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3beta and attenuated by lithium.
King TD; Bijur GN; Jope RS
Brain Res; 2001 Nov; 919(1):106-14. PubMed ID: 11689167
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effect of asiatic acid on rotenone-induced mitochondrial dysfunction and oxidative stress-mediated apoptosis in differentiated SH-SYS5Y cells.
Nataraj J; Manivasagam T; Justin Thenmozhi A; Essa MM
Nutr Neurosci; 2017 Jul; 20(6):351-359. PubMed ID: 26856988
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
Inden M; Kitamura Y; Tamaki A; Yanagida T; Shibaike T; Yamamoto A; Takata K; Yasui H; Taira T; Ariga H; Taniguchi T
Neurochem Int; 2009 Dec; 55(8):760-7. PubMed ID: 19647776
[TBL] [Abstract][Full Text] [Related]
17. Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage.
Lev N; Melamed E; Offen D
Neurosci Lett; 2006 May; 399(1-2):27-32. PubMed ID: 16584840
[TBL] [Abstract][Full Text] [Related]
18. Modulatory effects of sodium salicylate on the factors affecting protein aggregation during rotenone induced Parkinson's disease pathology.
Thakur P; Nehru B
Neurochem Int; 2014 Sep; 75():1-10. PubMed ID: 24852355
[TBL] [Abstract][Full Text] [Related]
19. Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway.
Lee HJ; Khoshaghideh F; Patel S; Lee SJ
J Neurosci; 2004 Feb; 24(8):1888-96. PubMed ID: 14985429
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein prevents the formation of spherical mitochondria and apoptosis under oxidative stress.
Menges S; Minakaki G; Schaefer PM; Meixner H; Prots I; Schlötzer-Schrehardt U; Friedland K; Winner B; Outeiro TF; Winklhofer KF; von Arnim CA; Xiang W; Winkler J; Klucken J
Sci Rep; 2017 Feb; 7():42942. PubMed ID: 28224980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]